Shinpoong Pharmaceutical Co.,Ltd (KRX:019175)

Market Cap	726.00B
Revenue (ttm)	222.50B
Net Income (ttm)	-13.49B
Shares Out	n/a
EPS (ttm)	-263.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	43,420
Average Volume	12,918
Open	21,850
Previous Close	21,750
Day's Range	21,050 - 28,250
52-Week Range	9,650 - 55,000
Beta	1.46
RSI	53.86
Earnings Date	Aug 14, 2025

About KRX:019175

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1962
• Employees: 819
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 019175

Financial Performance

In 2024, KRX:019175's revenue was 221.09 billion, an increase of 10.42% compared to the previous year's 200.23 billion. Losses were -14.82 billion, -74.15% less than in 2023.